Prostate cancer is the most frequently diagnosed cancer among American men and one of the least likely to kill them, a mismatch driven largely by how the disease is found. A diagnostic step now standard across most wealthy countries, an MRI scan before any biopsy, is still used in only about a third of United States cases.
With more than 333,000 new cases every year, prostate cancer is by far the most common cancer in American men. Only about 4 percent of prostate cancers end up being lethal, and the five-year survival rate is roughly 99 percent, according to reporting on the pre-biopsy MRI gap by STAT.
